File:Oculocutaneous albinism eyes.jpg: Difference between revisions

Latest revision as of 08:00, 1 November 2018

Figure 20: OCA1A patient eyes

The image shows the eyes of a patient with OCA1A. The iris is observed to be fully translucent and an ‘almost pink’ colour due to the lack of pigment development.

Reference

Grønskov, K., Ek, J. and Brondum-Nielsen, K. (2007). Oculocutaneous albinism. Orphanet Journal of Rare Diseases, 2(1), p.43.

Mark Hill (talk) 17:12, 30 October 2018 (AEDT) Shown below is the correct referencing format that should have been used here.

Grønskov K, Ek J & Brondum-Nielsen K. (2007). Oculocutaneous albinism. Orphanet J Rare Dis , 2, 43. PMID: 17980020 DOI.

Copyright

Mark Hill (talk) 08:59, 1 November 2018 (AEDT) All required information included. You could have given a little more detail to the description, including spelling out the acronym OCA1A as Oculocutaneous albinism, including a link to the OMIM entry for this disorder - OMIM 203100 OCA1A is caused by homozygous or compound heterozygous mutation in the tyrosinase gene (TYR; 606933) on chromosome 11q14.

Note - This image was originally uploaded as part of an undergraduate science student project and may contain inaccuracies in either description or acknowledgements. Students have been advised in writing concerning the reuse of content and may accidentally have misunderstood the original terms of use. If image reuse on this non-commercial educational site infringes your existing copyright, please contact the site editor for immediate removal.

File history

Click on a date/time to view the file as it appeared at that time.

	Date/Time	Thumbnail	Dimensions	User	Comment
current	23:09, 16 October 2018		755 × 113 (15 KB)	Z5164785 (talk \| contribs)	Figure 20: OCA1A patient eyes The image shows the eyes of a patient with OCA1A. The iris is observed to be fully translucent and an ‘almost pink’ colour due to the lack of pigment development. ====Reference==== Grønskov, K., Ek, J. and Brondum-N...

You cannot overwrite this file.

File usage

The following 2 pages use this file:

Revision as of 07:59, 1 November 2018 (view source) Z8600021 (talk \| contribs) mNo edit summary ← Older edit		Latest revision as of 08:00, 1 November 2018 (view source) Z8600021 (talk \| contribs) mNo edit summary
Line 14:		Line 14:


	[[User:Z8600021\|Mark Hill]] ([[User talk:Z8600021\|talk]]) 08:59, 1 November 2018 (AEDT) All required information included. You could have given a little more detail to the description, including spelling out the acronym OCA1A as Oculocutaneous albinism, including a link to the OMIM entry for this disorder [https://www.omim.org/entry/203100 OMIM 203100 OCA1A]		[[User:Z8600021\|Mark Hill]] ([[User talk:Z8600021\|talk]]) 08:59, 1 November 2018 (AEDT) All required information included. You could have given a little more detail to the description, including spelling out the acronym OCA1A as Oculocutaneous albinism, including a link to the OMIM entry for this disorder - [https://www.omim.org/entry/203100 OMIM 203100 OCA1A] is caused by homozygous or compound heterozygous mutation in the tyrosinase gene (TYR; 606933) on chromosome {{Chr11}}q14.


	{{Student Image}}		{{Student Image}}